| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $131.8M | +12.4% |
| Cost of Revenue | $96.4M | +13.2% |
| Gross Profit | $35.4M | +10.4% |
| R&D Expense | $1.7M | +23.4% |
| SG&A Expense | $10.2M | +21.1% |
| Operating Income | -$2.1M | -191.1% |
| Pre-tax Income | -$2.3M | -264.4% |
| Income Tax | -$548K | -167.8% |
| Net Income | -$1.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.6M | -41.0% |
| Accounts Receivable | $20.3M | +25.3% |
| Inventory | $14.0M | +40.6% |
| Current Assets | $52.9M | +14.7% |
| Total Assets | $75.5M | +14.8% |
| Current Liabilities | $42.5M | +51.7% |
| Total Liabilities | $53.9M | +29.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | -634.3% |
| Capital Expenditures | $2.2M | +162.5% |
| Investing Cash Flow | -$2.9M | -205.1% |
| Financing Cash Flow | $7.5M | +366.0% |
| Free Cash Flow | -$9.6M | -1853.4% |
| -263.7% |
| EPS (Basic) | -$0.13 | -262.5% |
| EPS (Diluted) | -$0.13 | -285.7% |
| Stockholders' Equity |
| $22.3M |
| -8.0% |